Revel Pharmaceuticals
Developer of therapeutic enzymes designed for degrading molecular damage associated with aging. The company's platform integrates enzyme discovery and engineering capabilities, encompassing design, op...
Valuation
$0
Share Price
N/A
Total Raised
$10.7M
Last Round
N/A